Home › NDC Lookup › RxCUI directory › RxCUI 1872458

Telotristat ethyl 250 MG Oral Tablet [Xermelo] — RxCUI 1872458

RxNorm drug concept · Semantic branded drug
RxCUI 1872458 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1872458
Official nameTelotristat ethyl 250 MG Oral Tablet [Xermelo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXermelo 250 MG Oral Tablet; Xermelo 250 MG (as telotristat etiprate 328 MG) Oral Tablet
FDA products mapped3
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Telotristat Ethyl: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Xermelo (telotristat ethyl) is a pill that specifically targets the root cause of your diarrhea — too much serotonin being made in your gut because of your carcinoid tumor. Your ot...
  • What exactly is Xermelo and why has my doctor added it to my other carcinoid treatment?
  • Always take Xermelo with food — this is important, not just a suggestion. Eating significantly increases how much of the medicine gets into your bloodstream where it can do its job...
  • Do I need to take Xermelo with food, or can I take it whenever?
📖 Read our full Telotristat Ethyl guide →

🕸️ Concept Web — How Telotristat ethyl 250 MG Oral Tablet [Xermelo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Telotristat ethyl 250 MG Oral Tablet [Xermelo] RxCUI 1872458

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Telotristat ethyl 1872441
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Xermelo 1872484
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Telotristat ethyl Oral Tablet 1872452
    • Telotristat ethyl Oral Product 1872450
    • Telotristat ethyl Pill 1872451
    • Telotristat ethyl Oral Tablet [Xermelo] 1872455
    • Xermelo Oral Product 1872456
    • Xermelo Pill 1872457
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Telotristat ethyl 250 MG Oral Tablet SCD · 1872453
  • Telotristat ethyl 250 MG SCDC · 1872449
  • Telotristat ethyl Oral Tablet SCDF · 1872452
  • Telotristat ethyl Oral Product SCDG · 1872450
  • Telotristat ethyl Pill SCDG · 1872451

Brand-Name Concepts

  • Telotristat ethyl 250 MG [Xermelo] SBDC · 1872454
  • Telotristat ethyl Oral Tablet [Xermelo] SBDF · 1872455
  • Xermelo Oral Product SBDG · 1872456
  • Xermelo Pill SBDG · 1872457
  • Xermelo BN · 1872484

📦 FDA Products & Package NDCs

3 products · 1 package NDC
1 package NDC map to RxCUI 1872458 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70720-0125-85 4 BOX in 1 CASE (70720-125-85) / 1 BLISTER PACK in 1 BOX (7... Xermelo TerSera Therapeutics LLC 2021-10-01
Observed labelers: TerSera Therapeutics LLC (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.